Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

48.00 -1.24 (-2.52%)
Streaming Delayed Price Updated: 1:37 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 461,152
Open 48.31
Bid (Size) 48.00 (100)
Ask (Size) 48.11 (100)
Prev. Close 49.24
Today's Range 46.17 - 48.35
52wk Range 23.30 - 51.80
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation
Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire

Performance

YTD
+48.2%
+48.2%
1 Month
+35.9%
+35.9%
3 Month
+55.0%
+55.0%
6 Month
+73.7%
+73.7%
1 Year
-1.3%
-1.3%

More News

Read More
News headline image
TWST Shares Rise 8% — What’s Driving The Rally? ↗
Via Stocktwits
Topics Artificial Intelligence
TWIST BIOSCIENCE CORP (NASDAQ:TWST) Reports Mixed Q1 FY2026 Results with Revenue Beat and Wider Loss ↗
Via Chartmill
News headline image
Twist Bioscience Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses ↗
Via Benzinga
News headline image
Twist Bioscience Corp (NASDAQ:TWST) Stock Falls After Q4 Earnings Miss ↗
Via Chartmill
Topics Earnings
News headline image
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings ↗
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2025 ↗
Via Benzinga
News headline image
Earnings Outlook For Twist Bioscience ↗
Via Benzinga
News headline image
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
Via Benzinga
News headline image
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design
From Twist Bioscience Corporation
Via Business Wire

Frequently Asked Questions

Is Twist Bioscience Corporation - Common Stock publicly traded?
Yes, Twist Bioscience Corporation - Common Stock is publicly traded.
What exchange does Twist Bioscience Corporation - Common Stock trade on?
Twist Bioscience Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Twist Bioscience Corporation - Common Stock?
The ticker symbol for Twist Bioscience Corporation - Common Stock is TWST on the Nasdaq Stock Market
What is the current price of Twist Bioscience Corporation - Common Stock?
The current price of Twist Bioscience Corporation - Common Stock is 48.00
When was Twist Bioscience Corporation - Common Stock last traded?
The last trade of Twist Bioscience Corporation - Common Stock was at 02/09/26 01:37 PM ET
What is the market capitalization of Twist Bioscience Corporation - Common Stock?
The market capitalization of Twist Bioscience Corporation - Common Stock is 2.44B
How many shares of Twist Bioscience Corporation - Common Stock are outstanding?
Twist Bioscience Corporation - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.